Survival Trends for Patients With AIDS

JAMA: The Journal of the American Medical Association

Volumn 263, Issue 3, 1990, Pages 402-406

  Lemp, George F ^a   Payne, Susan F ^a   Neal, Dennese ^a   Temelso, Tes ^a   Rutherford, George W ^a  

^a AIDS Office San Francisco   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; HUMAN; KAPOSI SARCOMA; NONHUMAN; PNEUMOCYSTIS CARINII; PNEUMONIA; PRIORITY JOURNAL; PROTOZOON;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; FEMALE; FOLLOW-UP STUDIES; HUMAN; MALE; MIDDLE AGE; PNEUMONIA, PNEUMOCYSTIS CARINII; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; SAN FRANCISCO; SARCOMA, KAPOSI; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL ANALYSIS; ZIDOVUDINE;

EID: 0025173899     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1990.03440030089027     Document Type: Article

References (26)

1. Rivin BE, Monroe JM, Hubschman BP, Thomas PA. AIDS outcome: a first follow-up. N Engl J Med. 1984;311:857.
2. Moss AR, McCallum G, Volberding PA, Bacchetti P, Dritz S. Mortality associated with mode of presentation in the acquired immune deficiency syndrome. JNCI. 1984;73:1281-1284.
3. Marasca G, McEvoy M. Length of survival of patients with acquired immunodeficiency syndrome in the United Kingdom. Br Med J. 1986;292:1727-1729.
4. Rothenberg R, Woelfel M, Stoneburner R, Milberg J, Parker R, Truman B. Survival with the acquired immunodeficiency syndrome: experience with 5833 cases in New York City. N Engl J Med. 1987;317:1297-1302.
5. Bacchetti P, Osmond D, Chaisson RE, et al. Survival patterns of the first 500 AIDS cases in San Francisco. J Infect Dis. 1988;157:1044-1047.
6. Fischl MA, Richman DD, Grieco MH, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med. 1987;317:185-191.
7. Fischl MA, Dickinson GM, La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA. 1988;259:1185-1189.
8. Golden JA, Chernoff D, Hollander H, Feigal D, Conte J. Prevention of Pneumocystis carinii pneumonia by inhaled pentamidine. Lancet. 1989;1:654-657.
9. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR. 1987;36(suppl 1S):1S-15S.
10. World Health Organization. Acquired immunodeficiency syndrome (AIDS): WHO/CDC definition for AIDS. WHO Weekly Epidemiol Rec. 1986;61:69-72.
11. Rauch KJ, Rutherford GW, Echenberg DF, et al. Surveillance of acquired immunodeficiency syndrome in San Francisco: evaluating the completeness of reporting. In: Official program of the 114th annual meeting of the American Public Health Association and related organizations; September 28-October 2,1986; Las Vegas, Nev. Abstract 1035.
12. Rutherford GW, Schwarcz SK, Lemp GF, et al. The epidemiology of AIDS-related Kaposi’s sarcoma in San Francisco. J Infect Dis. 1989;159:569-571.
13. Benedetti J, Yuen K, Young L. Life tables and survival functions. In: Dixon WJ, ed. BMDP Statistical Software. Berkeley: University of California Press; 1985:557-575.
14. Hopkins A. Survival analysis with covariates: Cox models. In: Dixon WJ, ed. BMDP Statistical Software. Berkeley: University of California Press; 1985:576-594.
15. The Long-term Survivor Study Group, Hardy AM. Characterization of long-term survivors of AIDS: a preliminary report. In: Final program and abstracts of the Fourth International Conference on AIDS; June 12-16, 1988; Stockholm, Sweden. Abstract 4594.
16. Reeves GK, Overton SE. Preliminary survival analysis of UK AIDS data. Lancet. 1988;1:880.
17. Chang HG, Mikl J, Morse D, Kain S, Putman D, Truman B. Survival experience of Upstate New York’s adult acquired immunodeficiency syndrome cases. In: Final program and abstracts of the Fourth International Conference on AIDS. June 12-16,1988; Stockholm, Sweden. Abstract 4591.
18. Anderson RM, Medley GF. Epidemiology of HIV infection and AIDS: incubation and infectious periods, survival and vertical transmission. AIDS. 1988;2(suppl 1):S57-S63.
19. Haley CE, Reff V, Freeman A, Haslund I, Karpf K, Bierman M. Improved survival of AIDS patients in Dallas, Texas after 1986. In: Abstracts of the Fifth International Conference on AIDS; June 4-9, 1989; Montreal, Canada. Abstract W.A.P. 81.
20. Lafferty W, Glidden D, Hopkins S, Harwell J, Honey J, Fields M. Increased survival for PWA. In: Abstracts of the Fifth International Conference on AIDS; June 4-9, 1989; Montreal, Canada. Abstract W. A. P. 82.
21. Volberding PA, Kusick P, Feigal DW. HIV antigenemia at diagnosis with Kaposi’s sarcoma: predictors of shortened survival. In: Final program and abstracts of the Fourth International Conference on AIDS; June 12-16, 1988; Stockholm, Sweden. Abstract 2644.
22. Wiley JA, Rutherford GW, Moss AR, Winkelstein W. Age and cumulative incidence of AIDS among seropositive homosexual men in high incidence areas of San Francisco. In: Final program and abstracts of the Third International Conference on AIDS; June 1-5, 1987; Washington, DC. Abstract F.1.4.
23. Goedert JJ, Eyster ME, Drummond JE, et al. The effect of age on HIV progression in hemophiliacs. In: Abstracts of the Fifth International Conference on AIDS; June 4-9, 1989; Montreal, Canada. Abstract Th.A.O.26.
24. Creagh-Kirk T, Doi P, Andrews E, et al. Survival experience among patients with AIDS receiving zidovudine: follow-up of patients in a compassionate plea program. JAMA. 1988;260:3009-3015.
25. Brenner M, Ognibene FP, Lack EE, et al. Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am Rev Respir Dis. 1987;136:1199-1206.
26. Justice AC, Feinstein AR, Wells CK. A new prognostic staging system for the acquired immunodeficiency syndrome. N Engl J Med. 1989; 320:1388-1393.